Polymorphisms of the matrix metalloproteinases associated with prostate cancer

Molecular Medicine Reports

Volumn 1, Issue 4, 2008, Pages 517-520

  Dos Reis, Sabrina Thalita ^a   Villanova, Fabiola Elizabeth ^a   De Andrade, Priscila Maria ^a   Pontes Jr , José ^a   Silva, Iran Amorim ^a   Canavez, Flávio Canelas ^b   Sañudo, Adriana ^a   Srougi, Miguel ^a   Leite, Kátia Ramos Moreira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Genoa Biotechnology   (Brazil)

Author keywords

Disease susceptibility; Metalloproteinases; Polymorphism; Prognosis; Prostate cancer

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN;

AGED; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENE FREQUENCY; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MALE; PROGNOSIS; PROSTATE CANCER; PROTECTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 69249090550     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.1.4.517     Document Type: Article

References (27)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer Statistics, 2007. CA Cancer J Clin 57: 43-66, 2007.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C and Thun MJ: Cancer Statistics, 2006. CA Cancer J Clin 56: 106-130, 2006.
3. Partin AW, Kattan MW, Subong EN, et al: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 277: 1445-1451, 1997. (Pubitemid 27208886)
4. Nelson AR, Fingleton B, Rothenberg ML and Matrisian LM: Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 18: 1135-1149, 2000. (Pubitemid 30123793)
5. Visse R and Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827-839, 2003. (Pubitemid 36542523)
6. Forget MA, Desrosiers RR and Beliveau R: Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis. Can J Physiol Pharmacol 77: 465-480, 1999. (Pubitemid 29500892)
7. Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174, 2002. (Pubitemid 37328786)
8. Curran S and Murray GI: Matrix metalloproteinases in tumor invasion and metastasis. J Pathol 189: 300-308, 1999. (Pubitemid 29489213)
9. Zinzindohoue F, Lecomte T, Ferraz JM, Houllier AM, Cugnene PH, Berger A, Blons H and Laurent-Puig P: Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer. Cin Cancer Res 15: 594-599, 2005. (Pubitemid 40116884)
10. Price SJ, Greaves DR and Watkins H: Identification of novel, functional genetic variants in the human matrix metallo-proteinase- 2 gene: role of SP-1 in allele-specific transcriptional regulation. J Biol Chem 276: 7549-7558, 2001. (Pubitemid 37392068)
11. Yu C, Pan K, Xing D, Liang G, Tan W, Zhang L and Lin D: Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res 62: 6430-6433, 2002. (Pubitemid 35364100)
12. Miao X, Yu C, Tan W, Xiong P, Liang G, Lu W and Lin D: A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306 C/T) is associated with risk of development but not metastasis of gastric cardiac adenocarcinoma. Cancer Res 63: 3987-3990, 2003. (Pubitemid 36917916)
13. Zhou Y, Yu C, Miao X, Tan W, Liang G, Xiong P, Sun T and Lin D: Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis 25: 399-404, 2004. (Pubitemid 38344407)
14. Zhang J, Jin X, Fang S, Wang R, Li Y, Wang N, Guo W, Wang Y, Wen D, Wei L, Dong Z and Kuang G: The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis 26: 1748-1753, 2005. (Pubitemid 41487990)
15. Allan JA, Docherty AJ, Barker PJ, Huskisson NS, Reynolds JJ and Murphy G: Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem J 309: 299-306, 1995.
16. O'Farrell TJ and Pourmotabbed T: Identification of structural elements important for matrix metalloproteinase type V collagenolytic activity as revealed by chimeric enzymes. Role of fibronectin-like domain and active site of gelatinase B. J Biol Chem 275: 27964-27972, 2000.
17. Hu Z, Huo X, Lu D, et al: Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer. Clin Cancer Res 11: 5433-5439, 2005. (Pubitemid 41060818)
18. Wright DK and Manos MM: Sample preparation from paraffin-embedded tissues. In: PCR Protocols: A Guide to Methods and Applications. Innis M (ed). Academic Press, San Diego, pp153-158, 1990.
19. Tlsty TD: Cell-adhesion-dependent influences on genomic instability and carcinogenesis. Curr Opin Cell Biol 10: 647-653, 1998.
20. Zhu Y, Spitz MR, Lei L, Mills GB and Wu X: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 61: 7825-7829, 2001. (Pubitemid 33049371)
21. Patterson BC and Sang QA: Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinaseB/type IV collagenase (MMP-9). J Biol Chem 272: 28823-28825, 1997.
22. Ohbayashi H: Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci 3: 409-421, 2002.
23. Lai HC, Chu CM, Lin YW, Chang CC, Nieh S, Yu MH and Chu TY: Matrix metalloproteinase 1 gene polymorphism as a prognostic predictor of invasive cervical cancer. Gynecol Oncol 96: 314-319, 2005. (Pubitemid 40127127)
24. Xu E, Lai M, Lv B, Xing X, Huang Q and Xia X: A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer. Biochem Biophys Res Commun 324: 999-1003, 2004. (Pubitemid 39361607)
25. Sfar S, Saad H, Mosbah F, Gabbouj S and Chouchane L: TSP1 and MMP9 genetic variants in sporadic prostate cancer. Cancer Genet Cytogenet 172: 38-44, 2007. (Pubitemid 44920266)
26. Clarizia AD, Bastos-Rodrigues L, Pena HB, Anacleto C, Rossi B, Soares FA, Lopes A, Rocha JC, Caballero O, Camargo A, Simpson AJ and Pena SD: Relationship of the methylenetetrahydrofolate reductase C677T polymorphism with microsatellite instability and promoter hypermethylation in sporadic colorectal cancer. Genet Mol Res 5: 315-322, 2007. (Pubitemid 43991970)
27. Ju W, Kim JW, Park NH, Song YS, Kim SC, Kang SB and Lee HP: Matrix metalloproteinase-1 promoter polymorphism and epithelial ovarian cancer: does ethnicity matter? J Obstet Gynaecol Res 33: 155-160, 2007.